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Introduction

Early 4-hydroxyperoxycyclophosphamide
(4-HC)
resistant
hematopoietic
progenitor
cells (preco lony-forming
units, pre-CFU) were evaluated by
a two-step liquid culture system, (earlier
progenitors),
pre-CFU, as well as by th e conventiona l semi-solid
mixed colony assay (later progenitors) for their growth response to interleukin-6
(IL-6), int erl e ukin-3 (IL-3), and a combination
of both factors.
The effect of the IL-6/IL-3
combination was compared to that of IL-l/IL-3.
IL-3 alone proved less effective
in supporting
ea rli er pre-CFU cells than later progenitor
ce ll s.
In a previous work IL-6 promoted the
growth of early multipotential
progenitor
cells
ci rculating
in hairy cell leukemia (HCL)
patients.
IL-6 alone did not stimulate
growth
of e ither ear ly or later normal progenitor
cells.
However, a significant
synergistic
effect was
obtained when IL-6 and IL-3 were added together
(p<0.05) . IL-6/IL-3 syner gism was more potent
than IL-l/IL-3
in promoting growth of colonies.
The previously
described synergis t ic effect
of
IL-1/IL-3 seems to be independent of IL-6.
Thus, our results
suggest that the multif unctional
cytokine IL-6, may be of use in
shortening
the engraftment
time in bone marrow
transplantation.

The formation of mature blood cells comes at
the end of a process which s tarts by th e proliferation of specifically
committed pro ge nitor cells
ca lled colony forming units (CFUs). Progenitor
ce lls as well as mature blood cells are tr ansit
populations
with little
capacity of se lf- generation (2,11).
Progenitor
cell numbers are maintained by th e proliferation
of a pre-CFU population among th em are ear l y hematopoietic
stem
ce lls.
These ce ll s are known to r eside in a noncyc ling s ta ge Go (8) but after ent eri ng the cell
cycle the y pos sess a distinct
se lf- ge nera tion
capac ity.
Ear ly human stem cells are dif ficu lt to
iso late and identify.
Ear ly progenitor
cell
pop ulation s can be enriched by positive
se l ect ion
with the CD34 (MylO) monoclonal antibody (3), or
by ne ga tive se lection of all known accessory
cells and committed progenitors.
Some investigator s use a blast colony assay to assess the early
pre-CFU population
(14).
4-hydroperoxycyclophosphamide (4-HC) has a sparing effec t on noncyc ling early ste m cells
(SJ, and eliminates
committed progenitors
(13).
This is supported by
the observation
that 4-HC treated marrow is capab le of r eco ns tituting
normal hematopoiesis
following autologous bone marrow tran sp lantation
(21).
4-HC and further enrichment by a two-step
sys tem, in which pre -CFU cells are "primed" in
liquid culture for one week, was used in our
laboratory
to s tudy the effe cts of different
co lony stimulating
factors
(CSFs) on the pre-CFU
ce lls.
Interleukin
3 (IL-3) ha s been shown by many
investigators
to be a multipotential
CSF (4,15)
acting on multipotential
progenitors,
i . e., CFUMix or CFU-GEMM(colony forming unit granu loc yt e,
erythroid,
macrophage and megakaryocyte),
but has
a lesser effect on pre-CFUs.
Other CSFs such as
GM-CSF (granulocyte/ macroph age CSF) and M-CSF
(macrophage CSF) act on committed progenitors.
Hematopoi etin-1
(HP-1), previously
termed
synerg istic
factor,
induces stem cells to become
responsive
to other CSFs (12).
HP-1 acts synergistically
with IL-3 in supporting proliferation
of ea rl y hematopoie tic progenitors
(1,25).
It is
now evident that most of the HP-1 activity
is due
to Interleukin-I
alpha (IL-1) (17).
Recently a
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a l so named Intercombination of Interleukin-6
feron-S-2 and IL-3 proved superior to IL-1 and
colony formation in 2-day post
IL-3 in supporting
SFU murine bone marrow (BM) cells (9).
Beta 2
6 also named Interferon
Interleukin
described and cloned
(IL-6/IFN- S2) was first
by its beta
from dsRNA induced human fibroblasts
(22,
activity
and anti-growth
IFN type an ti-viral
with
IFN- S2/IL-6 was found to be identical
27).
(BSF-2) and also with
factor
B-cell stimulating
(HSF) (20) . This
factor
hepatocyte stimulating
cytokine is produced in a regulamultifunctional
ted fashion by a varie t y of normal cells (e.g.,
fibroblas t s, endothe lial cells and monocytes).
The name IL-6 will be used in this work.
(TNF), platelet
factor
IL-1, tumor necrosis
(PDGF) and other cytokines
derived growth factor
(23).
of IL-6 in fibroblasts
tri gger expression
hematoof an indirect
Thus, the possibility
effect of IL-1 via IL-6 on stem cells
poietic
was also evaluated in the present work.
Earlier s tudi es in our l aboratory showed
that IL-6 was active on a special progenitor
lympho-GEMM
capability:
ce ll with multipotential
blood (PB) from
(LGEMM),found in peripheral
with Hairy Cell Leukemia (HCL) (16,20).
pa tients
cells than the
earlier
These cells may represent
CFU-Mix. The present work further demonstrates
that IL-6 also acts on normal ear l y hematopoietic
progenitors.
Materials

D., Revel M.

l eukocy t e condi tioned
PHA-LCM(phytohemagglutinin
medium). Al l plates contained 1 U/ml recombina nt
The
(Connaug ht, Ontario, Canada).
ery thropoietin
cultures were incubated in a fu lly humidi:ied
atmosphere containi ng 5% CO2 at 37 °c for : 4-16
When recombinant growth fac tor s were added
days.
no PHA-LCMwas included.
to the cultures
Liquid Culture: The ce ll s used in th :s twostep system (10) were tr eated as above with 4-HC,
in IMDMconta i ning
resuspended at 10 5 cells/ml
growth factors and incubated
10% FCS, different
with PHA-LCM
Control cultures
for 5 to 7 days.
as a pool of growth factors were inc lud e,d. At
were
period , the eels
the end of the incubation
e assay
and plated in the methylcellulos
pelleted
with PHA-LCMas a source of
as in day-0 cultures,
CSFs. The increase in th e number of secondary
the expansion of early progenicolonies reflects
tors in response to the primary stimulus during
the liquid phase.
of Colon y Types
Definition
according to their
Coloni es were classified
(Nikon,
appeara nce, using an inverted microscope,
Diaphot) as: CFU-Mix (colony forming units gra numacrophage and megakar yocytic)
locyte, erythroid,
CFU-GM (colony forming units granulocyte/macro
phage), BFU-E (burst forming units erythroid).
of cel l s within colonies is rou tin eThe identity
spreading on
ly checked by picking out colonies,
with Giemsa.
slides and staining
_
Factors
llematopoietic
Recombinant IL-6 (rIL-6) was supplied by
(Interpharm Nes-Ziona,
M. Revel and M. Rubinstein
rIL-6 from mammalian ce ll s was produced
Israel).
in Chinese Hamster ovary cells (CHO) clones (28).
(7).
Bacteria l rIL-6 was produced in E.coli
0.3 to 30 U/ml.
rTL-6 was use d at concentrations
(rIL-3) was used
Recombinant Interleukin-3
at 10 U/ml.
(rIL-1) was used
Recombinant Interleukin-I
at 2 U/ml.
from hybridoma
antibodies
Monoclona l anti-IL-6
clone 34 were s upplied from A. Zilberstein
of 1:100 to 1:500 in
Dilutions
(Weizmann Inst.).
IMDMwere used in the experiments.
Analysis
Statistical
Mean and Standard error of mean (SEM) for
dishes were assessed
colo nies grown in duplicate
and sets of data compared usin g th e Wilcoxon's
Rank test for unpaired samples.

and Methods

Bone Marrow Sampl es
Normal human bone marrow (BM) was obtained
with informed consent (according to the guidelines of the Helsinki Committee) from adults in
whom the bone marrow was not involved with any
pathology.
Blood Samples
Peripheral
PB sampl es were obtained from healthy adult
workers and also from HCL patients.
laboratory
Cell Separa tion Procedure
free
into preservative
BMand PB aspirated
heparin were separa ted over a Fico ll-H ypaque
(Pharmacia) at 400g for 30 min and the
gradient
washed 3
mononuclear cells collected,
interface
times and resuspended in Iscove's Modified Dulwas
becco's Medium (IMDM). T-cell depletion
sheep red blood cells
performed using AET treated
on a Ficollfo llowed by a second centrifugation
was
fraction
The T-depleted
Hypaque gradient.
then depleted of macropha ges by adherence to
pla stic at 370c overnight in IMDMwith 15% fetal
purity was over
calf serum (FCS). Preparation
90%.
(4-HC) treatment
4-hydroperoxycyclophosphamide
low
To enrich for early human progenitors,
BMand PB
non-rosetting
density non-adherent,
th e monoce ll s were tr eated with 4-HC. Briefly,
nuclear cells were incubated with 4-HC at lOOµg/
ml (as determined by a dose response curve) for
and
45 min at 37 0c with frequent agitations
washed three times with cold IMDM.
Colony Assays
10 5 cells were plated in 1ml
Day-0 cultures:
5xl0 5
0.9% methylcellulose,
of IMDMcontaining
10% FCS, 20% fresh
mg/ml 2-mercaptoethanol,
frozen plasma and when indic a ted 7.5% vol/vol

Results
co lon y formaEffect of rIL-6 on hematopoietic
tion in HCL-PB:
During our studies on the growt h of hematoblood (PB) of
poietic colonies from peripheral
(16), we observed that the
HCL leukemi a patients
addi tion of IFN-alpha or beta-1 species produced
a s li gh t but consis tent stimu lation in con trast
see n on normal hemawith the marked inhibition
The addition of rIL-6
progeni tors.
topoietic
(CHO) to PHA-LCMwhen compared to IFN-alpha,
of colony
pro duced a much l arger stimulation
gro wth in HCL-PB (not shown). rIL-6 alone also
cells in HCL-PB
st imulated growth of progenitor
as shown in fig. 1. A dose response curve of
The
colony formation in HCL PB was performed.
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Figure 1. Effect of rIL-6 (CHO) 0.3 U/ml on PB
progenitor
cells from HCL patients
in liquid
culture s . Results are mean of 6 independent
expe riments in duplicates.
(SD less than 10%).
optimal concentrations
were 0.03 to 30 U/ml of
recombinant IL-6 (fig.2).
In our experiments we
used 0.3 U/ml (anti-viral
U/ml).
Ef fect of rIL-6 on normal BMhematopoietic
colony formation
Monocyte and T-depleted
4-HC treated normal
bone marrow cells grown in the day-0 culture
assay with addition of rIL-6 (CHO), showed no
sign ificant
increase in CFU-GM, BFU-E and CFUMix. These results
greatly differed
from the 5
fo ld stimulation
in colony growth produced by
rIL-3 alone
(fig.3).
rIL-6 (CHO) when added to
rIL-3 however, promoted a slight
increase as
compared to rIL-3 alone (20 % increase of all
colony types).
These cu l tures were grown without
PHA-LCM.
We next compared the combination rIL-6 (CHO)
and rIL-3 on earlier
progenitor
cells in the
liquid two step assay.
rIL-3 alone was much less
effective
than in the day-0 cultures.
The incre ase in colony formation with rIL - 3 was only
slightly
greater than rIL - 6 alone (fig. 3) . rIL-3
in day - 0 cultures
replaced PHA-LCMcomplete l y,
but had a much less prominent effect on the
earlier
quiescent pre-CFU cells.
When the preCFU cells .were incubated with rIL-3 and rIL-6
(CHO), a clear synergism was demonstrated
(fig.
3).
When ana l yzing different
progenitor
cell
types, a major increase in CFU-GMwas evident in
day-0 cultures
whi l e in the liquid assay an
increase occurred mainly in BFU-E and CFU-Mix
(fig.4 ) . It is possible
that the cycling progeni t ors namely CFU-GMwere no l onger avai l able
in th e liquid assay and therefore
rIL-6/rIL-3
cou l d not infl uence t heir prolifera t ion .
iIL-6 produced i n E.co l i in duce d simi l ar
ef fects to CHO (fig.5) . When added a l one , no
s t imul ation of colony growth was obt ained in day0 cu lt ures (left col umns, fig.5) whi l e a slig ht
s t i mulation of colony growth was observed in th e
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Figure 4. Different
BMcells
10 5 depleted 4-HC treated
and liquid cultures.
evaluated in day-0 cultures
rIL-3 combination,
rIL-6 (CHO) 0.3 U/ml; rIL-3,
Results are mean of 5 experiments in duplicates.
per ml of culture.
are s hown on right and left pannel,respectively.
10 U/ml. Day-0 and liquid cultures
260

(right columns, fig. 5). A sig liquid cultures
synergism was obtained when both rIL-3
nificant
and rIL-6 were added togeth er in the two assays
as shown in fig. 5 (p<0 . 05). The number of all
in day-0 cultures with the
colonies increased
combination of rIL-6 and rIL-3 (fig . 6) . In the
a pronounced increase was see n in
liquid cultures
CFU-Mix, a small effect in BFU-E and almost none
rIL-3 alone promoted
in CFU-GM(fi g.6) , i.e.,
growth of 15 CFU-Mix colonies as compared to 35
(fig . 6). The results
CFU-Mix with rIL-6/rIL-3
shown in figures 3 and 5 re l at e t o th e number of
colonies obtained with rIL-3 and are expressed as
of percent increase are
100%. The calculations
derived from the number of colonies scored, shown
in figs. 4 and 6,respectively.
berIL - 1 when added alone to the cultures
haved si mila rl y to rI L-6 and did no t pro mote
However, synergism betwee n
growth of colonies.
In exper irIL-1 and rIL-3 was observed (fig . 5).
ments comparing t he combination rIL - 1/rIL-3 vers us
rIL-6/rIL - 3, the former combination proved l ess
To c he ck
effec t ive i n s t i mul at i ng growt h (f i g.5).
whe th er rI L-1/r I L-3 sy nergism is due t o prod uc tion
of IL - 6 by some re mai nin g accesso r y ce ll s we use d
The additio n of
monoclona l ant ibodies.
anti-IL-6
anti -I L-6 antibodies did not a lt er th e synergis m
effec t s were obt ai ned with r IL - 1
and no additive
and rI L- 6, sugges t ing t ha t t he two cy t okines ac t
each on i t s own (da t a not sho wn).
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Results are mean of 7 experiments in duplicates.
rIL-3, 10 U/ml rlL-6, 3 U/ml.
Discussion

We have confirmed the rIL-1/rIL-3
synergism and
found that rIL-6/rIL-3
is a more active combination.
Both rIL-1 and rIL-6 are multifunctional
cytokines involved in the immune response and
other important biological
processes.
Induction
of IL-1 by IL-6 accounting for the pre-CFU cells
response seems improbable since addition of monoclonal antibodies
to IL-6 did not abolish the
IL-1/IL-3 effect and no additive growth responses
were obtained when both rIL-1 and rIL - 6 were used
together .
It is not yet clear whether IL-6 acts
directly
on the stem cells . To answer this question, higher purity of target cells i.e . , CD34
MylO positive cells and the 4-HC two step assay
are needed.
Possible influence of T accessory
cells known to be activated by IL-6 (26), or
influence of other factors produced by stromal
elements in the microenvironment also remain to
be eva luated . In any case, the synergistic
effect obtained with rlL-6 and rIL-3 suggests
that this combination may be useful in fastening
reconstitution
of hematopoiesis
in bone marrow
transplantation.
The IL-6/IL-3 synergism may
prove equal or superior to other combinations
already tried in vivo (6).

The results of our study show that rIL-6
plays a role in "priming" early progenitor
cells
to respond to rIL-3.
To study pre-CFU cell responses, T and monocyte depleted bone marrow cells
after 4-HC treatment were "primed" in the liquid
two step culture assay with hematopoietic
factors
including rIL-6, and then checked for growth
response in methylcellulose
assays.
Using this
model, we show that rlL-6 by itself
does not
support colony formation indicating
that it does
not act by itself
as a growth promoting CSF. Only
when both rlL-6 and rIL-3 are present a clear
synergism can be demonstrated.
Different types
of progenitor cells were stimulated to grow by
the rIL-6 and rIL-3 combination.
In the two step
system, using either CHOor E.Coli rIL-6, mainly
BFU-E and CFU-Mix colonies proliferated
while in
the day - 0 cultures CFU-GMpredominated (fig .6).
This variability
in cell type response has not
been described previously,
and may suggest two
different
hematopoietic
effects of rIL-6 : A
priming effect on pre-CFU cells and a differentiating
effect on granulocyte/macrophage
lineage.
rIL-6 has also been shown to be capable of inducing differentiation
of leukemic mouse cells
(24) and increase of receptors for IL-3 and GMCSF has been reported for IL-6/IFN- $2/MG12 on
leukemic cells (19,24).
The lack of effect on
CFU-GMmay also be due to the fact that these are
later progenitors
and maybe eliminated by 4-HC in
the 5 days cultures,
therefore not responding to
rIL-6.
Interleukin
1 is another cytokine capable of
priming pre-CFU cells to respond to rIL-3 (18).
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Discussion

IL-6 IL-3 are of a magni tude of approxima t e l y
1:1000.
This can be augmented by thor ough l y
dep l eted sa mples with a panne l of monoclon a l
ant ibodies specific
for l ineage depe nd en t cel l s
and treatment with 4-HC or 5~U, that kill cyclin
cycling ce ll s and spare engraftin g hematopoietic
progeni t or cells.

with Reviewers
H. Gamli el : Could you briefly
review r eports on
s t em cells in th e peripheral
blood of leukemic
patients,
mainly, in hairy ce ll l eukemia (HCL).
Is it possible to positive l y iden ti fy such cells
in blood sampl es from HCL just by immunolabeling
them, e.g., for CD34? In cases of HCL, are th e
circu l at ing progenitor
cells different
from the
progenitor
cel l s common to the B-cel l and monocy t ic lineages?
Authors:
The presence of lymphomyeloid stem
cel l s with high self renewa l and lymphoid
differentiative
capability
in HCL was described
by us in 1987 (16).
We then showed that these
primitive
precursors
bear th e CD34 antigen
(Leukemia Researc h, in press).
Not all CD34
positive
ce ll s however are stem ce ll s but rather
consist of a frequency of 1 :100, 1:50 at the best
conditions . We do not know yet if these s tem
ce ll s are normal s t em ce ll s circu l ating in the
blood of HCL patients
as a response to the fibrosis and leukemic process in th e marrow, or if
those are early cells that und erwent a maturational arrest
causing accumulation of prep l as matic B ce ll s (hairy cells) . A chromosoma l or
enzymati c marker would help clarify
thi s important issue of cause or consequence.
The cells
common to Band monocytic linea ges ar e not the
sa me as the circulating
pro ge nitor ce ll s in HCL.
Little
is known in man abou t characteriza
tion of
the l ymphoid - stem ce ll arm in hematopoietic
development.

H. Gaml iel:
The present study used li ght micro s copy and cytoc hemical stains to identify
colonies.
Indeed, it appears that light microscopy might suffice
to dis tin guish between Mix,
GMand BFU-E colonies . Would you agree that
e l ectron microscopy in conjunction
with immunolab elin g may enable even better
iden ti fication
of
co l onies and sub - colonies,
e .g., G and M subco l onies etc.?
Also, why l ymphocytes are not
represented
in any of th e above colonies ? Should
not they be part of the CFU-Mix colonies?
Authors:
Electron microscopy with immunolabeling would be of great help in identifying
lymphoc yt es . It may be too cumbersome for a
routin e work or big number of exper iment s but in
the context of a pertinent
research it would
definitive l y add in characterization
of lymphocy te s . There are no l ymphocytes (by morphology)
that grow in mixed co l onies (CFU-Mix) from normal
blood or bone marrow and the reason for it is not
ye t enti rely clear.
Some attribute
it to th e age
of progenitor
cells that are a l lowed to gro w
under the given cu ltur e conditions
but it may
a lso be that so me factors are lackin g that
promote l ymphocytic diff ere ntiation.
Lymphocytes
deriv ed from a common lymphomye l oid progenitor
have been described in stem cell diseases
and,
recently
by us, in hairy cel l leuk emia (ref 16).
H. Gamliel:
Could you comment on what actua ll y
trigger s ear l y hema t opoietic
stem ce lls to ent er
the ce ll cycle, mainl y , if priming pre -CFU ce ll s,
as presently
reported,
also leads to changes in
the self ge neration capacity of th ese cells,
besides turning th e cells responsive
to ot her
gr owth factors?
Autho rs:
Early hematopoietic
s t em ce ll s are
qui escent ce ll s (Go phase) and there is l ack
of knowledge as to what triggers
them to enter
the cell cycle.
I t seems that IL-6 may be
capab l e of doin g this by promoting the cells to
respond to IL- 3. Other candidates
would be GCSF and IL-1.
This que s tion is crucial
and I
be l ieve that th e answer wi ll be possible
when
true stem cel l s are isolated
and fu ll y characterized.

P.M. Grimley: How many different
blood sampl es
were examined to determine th e s tatistic
al
va lidit y of IL-3/IL-6 sy nergi sm? Whil e th e
Wil coxon rank t es t is usefu l, da t a fro m just one
sa mple woul d not nece ssari l y indicate
biolo gic
consistency.
Autho rs:
Five different
marrow samples were
e xamined to determine th e IL-3/IL-6 synergism.
This is s tat ed in th e l ege nd for fig. 3.
P.M. Griml ey: Have ther e been any ce ll cycle
ana l ysis of pre -CFU cells af t er one week in the
li quid medium? Are such result s consistent
amongst sampl es fro m different
individuals?
Since
marrow pro l iferative
ac ti vity gra dually declines
with age, was thi s a factor with differen t
donors?
Do the colonies obtained from day-0
cultures and af t er pr iming di ffer sta ti stica ll y
in ce ll cyc l e distributions,
af t er for exa mple
IL-3 + IL - 6 .tre atment s hown in fig. 3?
Authors : We have not analysed cell cycl e. It
is howeve r known that earlier
stem cells are
quiesc en t (in Go). In th e Ogawa publication
(t ex t, ref. 15) cited in references
ther e are
s ome evidences suggestin g that IL-6 may shorten the time in Go th erefore enabling cells
to respond to IL-3.
It may be true that
older donors may have l ess colony growth . We

H. Gamli e l: What are the ac tu a l numbers of preCFU ce ll s that are left af t er tr eat in g a bone
marrow aspirate?
If for exampl e you s tart with
10x10 6 mononuclear ce ll s, how many pre-CFU cells
can be harvested from such a sample?
Authors:
The liquid culture assay used for
pre-CFU cells is a modification
of the
Johnson and Bradley t ype of assay for s t em ce ll s
in the mouse. It i s based on th e conc ep t of a
qui escen t s t at e of s t em ce lls and sho uld a llow
enric hmen t for earl i er non-cycling
ce ll s. The
numbers of pre-CFU cells that are left after
treating
a bone marrow aspi rat e when exposed to
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have not examined thoroughly this question
and thus cannot comment further on this point.
I cannot find the data which
P.M. Grimley:
supports your statement that IL-3 is much less
in supporting pre-CFU cells assayed by
effective
This is not
the two-step liquid culture system.
for example in fig. 3.
apparent,
Our
right.
You are entirely
Authors:
statement is not apparent if one looks only at
of
fig. 3 where we choose to show the effects
rIL-6 and synergism between rIL-6 and rIL-3 as
the
Therefore,
related to the rIL-3 activity.
are
of both day-0 and liquid cultures
results
shown as related to growth with rIL-3 (considered
are evident if one looks
100%). The differences
at the data showing actual colony numbers in
figs. 4 and 6. IL-3 indeed was a less stronger
inducer of colony growth in the pre-CFU assay as
effect on day-0
compared to its stimulatory
on CFU-Mix. This is in accordance with
cultures
the findings of most groups working on stern
of
IL-3 is a very potent stimulator
cells.
early stages of hernatQgrowth at relatively
but probably not on the
poietic precursors
The common adopted view
pre-CFU cells.
earliest
of most workers in this field is that IL-3 is
not the "stern cell factor" and its response is
mainly on cells that were first primed and prefactors.
pared to respond to IL-3 by earlier
Among these are IL-6 and IL-1 as well as G-CSF.
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